Innovation in Catheter-Directed Therapy for Intermediate-High-Risk and High-Risk Pulmonary Embolism
JACC: Cardiovascular Interventions · 2024
DOI: 10.1016/j.jcin.2024.07.033 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift JACC: Cardiovascular Interventions, 2024. Verfasst von Marco Zuin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medicine, University of Ferrara, Ferrara, Italy; Department of Cardio-Thoraco-Vascular Sciences and Public Health, Univer…. Hauptthemen laut MEDLINE: Pulmonary Embolism, Thrombolytic Therapy, Fibrinolytic Agents, Anticoagulants. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 53 Literaturangaben.
Abstract (Originalsprache)
Although anticoagulation remains the cornerstone treatment for patients with acute pulmonary embolism (PE), catheter-directed therapy (CDT) has generated great interest as an adjunctive option for those presenting with hemodynamic decompensation or high risk for deterioration and in whom systemic thrombolysis has failed or is contraindicated. However, randomized controlled data supporting the efficacy and safety of CDT in addition to antithrombotic therapy in patients with high-risk and intermediate- to high-risk PE compared with anticoagulation and systemic thrombolysis alone are lacking. This paucity of high-quality data hampers guideline recommendations regarding the optimal therapeutic approach in such patients with PE. The aim of the present paper is to critically appraise the current evidence for CDT in patients with high-risk and intermediate- to high-risk PE and to highlight major areas of innovation in the recent literature. In addition, the authors describe unmet clinical and research needs, potential strategies to resolve these knowledge gaps, and pathways for device selection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Translational Medicine, University of Ferrara, Ferrara, Italy; Department of Cardio-Thoraco-Vascular Sciences and Public Health, University of Ferrara, Ferrara, Italy. Electronic address: zuinml@yahoo.it.
- Clinical Division of Cardiology, Department of Medicine II, Medical University of Vienna, Vienna, Austria.
- Department of Cardiology, University Hospital Jean Minjoz, Besançon, France.
- Department of Cardiology, University Hospital of Wales and Cardiff University, Cardiff, United Kingdom.
- Cardiovascular Research Institute Dublin and Department of Cardiology, Mater Private Network, Dublin, Ireland; School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Irela…
- Department of Cardiology, Ospedali Riuniti Padova Sud, Schiavonia, Padova, Italy.
Zitieren
APA
Zuin, M., Lang, I., Chopard, R., Sharp, A. S. P., Byrne, R. A., Rigatelli, G., & Piazza, G. (2024). Innovation in Catheter-Directed Therapy for Intermediate-High-Risk and High-Risk Pulmonary Embolism. JACC: Cardiovascular Interventions. https://doi.org/10.1016/j.jcin.2024.07.033
Vancouver
Zuin M, Lang I, Chopard R, Sharp ASP, Byrne RA, Rigatelli G, et al. Innovation in Catheter-Directed Therapy for Intermediate-High-Risk and High-Risk Pulmonary Embolism. JACC: Cardiovascular Interventions. 2024. doi:10.1016/j.jcin.2024.07.033
BibTeX
@article{Zuin2024,
author = {Zuin, Marco and Lang, Irene and Chopard, Romain and Sharp, Andrew S P and Byrne, Robert A and Rigatelli, Gianluca and Piazza, Gregory},
title = {Innovation in Catheter-Directed Therapy for Intermediate-High-Risk and High-Risk Pulmonary Embolism},
journal = {JACC: Cardiovascular Interventions},
year = {2024},
doi = {10.1016/j.jcin.2024.07.033}
}
EUVIMED